Regional Covid-19 Resources and On Reserve Stats by Region Below:
Black = New Cases, Green = Recovered, Red = Deaths, Blue – Hospitalized, Purple – ISC reported total –  Updated Daily

BC
14 458 158 8,632 8,804
AB
9 1,046 185 20,082 20,311
SK
0 495 129 16,186 16,343
MB
4 901 155 25,118 25,283
ON
81 365 80 21,111 21,459
QC
86 115 26 13,653 13,793
Atlantic
0 14 9 4,614 4,658
North60
10 326 56 19,406 19,499
 

Pfizer seeks U.S. authorization of COVID vaccine for young children – CTV

June 2, 2022

WASHINGTON – The U.S. Food and Drug Administration set June 14-15 as the new meeting date to review Moderna Inc’s emergency authorization request for its COVID-19 vaccine for children aged 6 months to 5 years and Pfizer Inc’s vaccine for those aged 6 months through 4 years.
The new dates for our pediatric COVID-19 vaccine advisory committee meetings will now be June 14 and June 15, the FDA said in a statement Monday.

“We know parents are anxious for us to determine if these vaccines are safe & effective. In light of the disclosure by Pfizer re: their data & anticipated dates for submission, we believe that we will complete review of both EUA requests within days of one another,” it said.

The June 14 meeting will consider Moderna’s emergency use authorization request for youth aged six to 17 years, the FDA said.

White House COVID-19 response coordinator Dr. Ashish Jha said on Sunday he expects a U.S. Food and Drug Administration decision on authorizing Moderna’s vaccine for children under age five within the next few weeks.

Read more: https://www.ctvnews.ca/health/coronavirus/pfizer-seeks-u-s-authorization-of-covid-vaccine-for-young-children-1.5929289

NationTalk Partners & Sponsors Learn More